ATRO

Business Context and Reporting Period

Company: Astronics Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: October 3, 2009
Business Overview: Astronics operates in two segments: Aerospace (aircraft lighting, cabin electronics, airframe power) and Test Systems (military test, training, and simulation equipment). The Test Systems segment was established following the acquisition of DME Corporation on January 30, 2009.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Consolidated sales increased 12.6% year-to-date and 20.4% in the third quarter. This growth is primarily driven by the DME acquisition, which contributed $38.4 million to YTD sales and $14.1 million to Q3 sales. Excluding DME, organic revenue declined due to reduced business jet build rates and lower commercial airline spending.
• Profitability Decline: Net income decreased 42.3% year-to-date ($5.9M vs $10.1M). This was caused by lower organic sales volume, increased interest expense from acquisition debt, and higher SG&A expenses related to DME integration and intangible asset amortization.
• Margin Compression: Gross margin decreased to 18.8% YTD from 22.1% in 2008. The decline reflects lost margin on lower organic sales volume and lower initial margins in the acquired DME business.
• Balance Sheet Expansion: Total assets increased from $104.7 million to $157.9 million, and total debt increased significantly from $14.4 million to $53.1 million to fund the DME acquisition.
• Unusual Items: The company recognized $1.0 million in "Other Income" YTD due to a fair value adjustment on a contingent $2.0 million subordinated note payable related to the DME acquisition. The company determined the probability of meeting the revenue performance criteria was remote, reducing the note's fair value to zero.

Guidance, Outlook, and Risks

• 2009 Revenue Guidance: Management expects consolidated revenue for the full year 2009 to be in the range of $190 million to $195 million. Segment-specific guidance is $156M-$159M for Aerospace and $34M-$36M for Test Systems.
• 2010 Outlook: Management does not expect sales improvement in 2010 compared to 2009 and anticipates a potential slight decline. Key headwinds include the conclusion of the Tactical Tomahawk program and continued weakness in business jet and commercial transport markets.
• Liquidity and Debt Covenants: While the company currently has $21.5 million available on its revolving credit facility, management warns of an "increased possibility of noncompliance" with financial covenants (fixed charge coverage and leverage ratios) if financial forecasts are not met. A breach would result in a default, requiring waivers and likely incurring additional financing costs.
• Customer Concentration: Significant reliance on two customers: Panasonic Avionics Corporation (~20% of Q3 revenue) and the U.S. Government (~22% of Q3 revenue).
• Accounting Risks: The Test Systems segment uses the percentage-of-completion method for long-term fixed-price contracts. Management notes that unforeseen events could cause ultimate gross profit to vary significantly from estimates.

Investor Verification Checklist

• Debt Covenant Compliance: Verify the company's ability to meet fixed charge coverage and leverage ratios given the lower-than-expected sales and profits in 2009.
• Organic Revenue Trends: Assess the sustainability of the decline in organic sales, particularly in the business jet and commercial transport markets.
• DME Integration: Monitor the performance of the Test Systems segment, which currently shows low operating margins (1.6% YTD) and weak new order bookings.
• Contingent Consideration: Confirm the status of the $2.0 million contingent note payable to DME sellers and the likelihood of any future payment obligations.
• Backlog Quality: Review the $101 million backlog, specifically the mix of firm fixed-price contracts in the Test Systems segment versus the Aerospace segment.